Journal
CANCER CELL
Volume 2, Issue 3, Pages 183-192Publisher
CELL PRESS
DOI: 10.1016/S1535-6108(02)00127-7
Keywords
-
Categories
Funding
- NCI NIH HHS [CA 92625] Funding Source: Medline
Ask authors/readers for more resources
The BH3-only proteins of the BCL-2 family require multidomain proapoptotic members BAX and BAK to release cytochrome c from mitochondria and kill cells. We find short peptides representing the alpha-helical BH3 domains of BID or BIM are capable of inducing oligomerization of BAK and BAX to release cytochrome c. Another subset characterized by the BH3 peptides from BAD and BIK cannot directly activate BAX, BAK but instead binds antiapoptotic BCL-2, resulting in the displacement of BID-like BH3 domains that initiate mitochondrial dysfunction. Transduced BAD-like and BID-like BH3 peptides also displayed synergy in killing leukemic cells. These data support a two-class model for BH3 domains: BID-like domains that activate BAX, BAK and BAD-like domains that sensitize by occupying the pocket of antiapoptotic members.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available